MedPath

Which oxygen saturation level should we use for very premature infants? A randomised controlled trial (BOOST-II UK) - BOOST-II UK

Phase 1
Conditions
Respiratory distress of newbornICD codes P22.0, P22.8, P22.9
Registration Number
EUCTR2005-006174-97-GB
Lead Sponsor
niversity of Oxford, Research Governance & Clinical Trials Office
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
0
Inclusion Criteria

Infants are eligible if they are:

(a) they are less than 28 weeks’ gestation at birth and
(b) they are less than 12 hours old (24 hours old if the baby is outborn) and
(c) the clinician and parents are substantially uncertain which SpO2 is better and
(d) the parent(s) have given written informed consent to their baby’s participation

Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Recruitment is not appropriate if there is no realistic prospect of survival, or follow-up is unlikely to be possible.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath